General NSABP Information
  Contact the NSABP
  Pathology Section
  Future Meetings
  NSABP Newsletters
  Media Info on cMYC Study
Clinical Trials Information
  Clinical Trials Overview
  Protocol Chart
  Never Say Lost
Treatment Trials Information
  Protocol B-35
  Protocol B-36
  Protocol B-37
  Protocol B-38
  Protocol B-39
  Protocol C-08
  Protocol C-09
  Protocol R-04
Prevention Trials Information
  Protocol P-1 - BCPT
  Protocol P-2 - STAR
  Protocol P-3 - PPP
  BreastCancerPrevention.com
Bibliography of Publications

Related Web Sites

About the NSABP Web Site


NSABP Members' Area
  Password Protected - Access
  Limited to NSABP Participating
  Institutions Only


Helper Applications
Links to Major Search Engines
Medical Search Engines


To report problems, ask
questions or make comments,
please send e-mail to:
 Webmaster@nsabp.pitt.edu


The Study of Tamoxifen and Raloxifene, or STAR, is one of the largest breast cancer prevention studies ever. This five year study aims to recruit 19,000 volunteers at more than 400 centers across the United States, Puerto Rico, and Canada.